ADIPOQ and metabolic dysfunction-associated steatotic liver disease: Compared with non-obese controls, patients with NAFLD without obesity had higher fasting glucose levels and a lower adiponectin-to-leptin ratio (Supplementary Table 1 and Fig. 7c–e).